Citation: J. Gillies et al., SEVERE VINCRISTINE TOXICITY IN COMBINATION WITH ITRACONAZOLE, Clinical and laboratory haematology, 20(2), 1998, pp. 123-124
Authors:
SOUTAR R
GILMOUR S
ANDERSON S
FITZSIMONS E
Citation: R. Soutar et al., THE USE OF CD34 COUNTS TO PREDICT THE SUCCESS OF STEM-CELL COLLECTIONS, British Journal of Haematology, 101, 1998, pp. 272-272
Authors:
HOLYOAKE TL
ALCORN MJ
RICHMOND L
FARRELL E
PEARSON C
GREEN R
DUNLOP DJ
FITZSIMONS E
PRAGNELL IB
FRANKLIN IM
Citation: Tl. Holyoake et al., CD34 POSITIVE PBPC EXPANDED EX-VIVO MAY NOT PROVIDE DURABLE ENGRAFTMENT FOLLOWING MYELOABLATIVE CHEMORADIOTHERAPY REGIMENS, Bone marrow transplantation, 19(11), 1997, pp. 1095-1101
Authors:
ALCORN MJ
HOLYOAKE TL
RICHMOND LJ
PEARSON C
FARRELL E
GREEN R
DUNLOP DJ
FITZSIMONS E
FRANKLIN IM
Citation: Mj. Alcorn et al., IMPROVED EX-VIVO EXPANSION OF CD34 SELECTED PBPC USING HIGH EXPANSIONCULTURE BAGS, British Journal of Haematology, 93, 1996, pp. 159-159
Authors:
HOLYOAKE TL
ALCORN MJ
RICHMOND L
PEARSON C
FARRELL E
KYLE B
DUNLOP DJ
FITZSIMONS E
STEWARD WP
PRAGNELL IB
FRANKLIN IM
Citation: Tl. Holyoake et al., AN EVALUATION OF THE FEASIBILITY OF USING CD34 POSITIVE CELLS EXPANDED EX-VIVO FOR TRANSPLANTATION, British Journal of Haematology, 93, 1996, pp. 162-162
Authors:
HOLYOAKE TL
FRESHNEY MG
MCNAIR L
PARKER AN
MCKAY PJ
STEWARD WP
FITZSIMONS E
GRAHAM GJ
PRAGNELL IB
Citation: Tl. Holyoake et al., EX-VIVO EXPANSION WITH STEM-CELL FACTOR AND INTERLEUKIN-11 AUGMENTS BOTH SHORT-TERM RECOVERY POSTTRANSPLANT AND THE ABILITY TO SERIALLY TRANSPLANT MARROW, Blood, 87(11), 1996, pp. 4589-4595
Authors:
HOLYOAKE TL
ALCORN MJ
RICHMOND L
PEARSON C
FARRELL E
KYLE B
DUNLOP DJ
FITZSIMONS E
PRAGNELL IB
FRANKLIN IM
Citation: Tl. Holyoake et al., A FEASIBILITY STUDY OF EX-VIVO EXPANSION OF CD34 POSITIVE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) ON A CLINICAL-SCALE, Experimental hematology, 23(8), 1995, pp. 760-760
Authors:
ALCORN MJ
HOLYOAKE TL
RICHMOND LJ
PEARSON C
FARRELL E
KYLE B
DUNLOP DJ
FITZSIMONS E
STEWARD WP
PRAGNELL IB
FRANKLIN IM
Citation: Mj. Alcorn et al., CD34 SELECTION USING THE BAXTER-ISOLEX-300 SYSTEM - COMPARISON BETWEEN FRESH PBPC AND CRYOPRESERVED PBPC, Blood, 86(10), 1995, pp. 907-907
Authors:
HOLYOAKE TL
ALCORN MJ
RICHMOND L
PEARSON C
FARRELL E
KYLE B
DUNLOP DJ
FITZSIMONS E
STEWARD WP
PRAGNELL IB
FRANKLIN JM
Citation: Tl. Holyoake et al., A PHASE-I STUDY TO EVALUATE THE SAFETY OF RE-INFUSING CD34 CELLS EXPANDED EX-VIVO AS PART OR ALL OF A PBPC TRANSPLANT PROCEDURE, Blood, 86(10), 1995, pp. 1161-1161
Authors:
HOLYOAKE TL
ALCORN MJ
RICHMOND LJ
FRESHNEY MG
PEARSON C
FITZSIMONS E
STEWARD WP
DUNLOP DJ
PRAGNELL IB
Citation: Tl. Holyoake et al., EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING, Stem cells, 12(1), 1994, pp. 114-124
Authors:
HOUSTON T
MOORE M
PORTER D
STURROCK R
FITZSIMONS E
Citation: T. Houston et al., ABNORMAL HEME-BIOSYNTHESIS IN THE CHRONIC ANEMIA OF RHEUMATOID-ARTHRITIS, Annals of the Rheumatic Diseases, 53(3), 1994, pp. 167-170
Authors:
HOLYOAKE TL
FRESHNEY MG
SPROUL AM
RICHMOND LJ
ALCORN MJ
STEWARD WP
FITZSIMONS E
DUNLOP DJ
FRANKLIN IM
PRAGNELL IB
Citation: Tl. Holyoake et al., CONTRASTING EFFECTS OF RH-MIP-1-ALPHA AND TGF-BETA(1) ON CHRONIC MYELOID-LEUKEMIA PROGENITORS IN-VITRO, Stem cells, 11, 1993, pp. 122-128